MMP9 and metastatic malignant neoplasm in the lymph nodes: Matrix metalloproteinase 9 (MMP-9), associated with lymph node metastasis and reduced survival rates, is synergistically upregulated by pro-inflammatory cytokines and growth factors in an NF-κB-dependent manner (63, 64).